Indrayani Biotech Ltd.

BSE: INDRANIB526445ISIN INE007C01021

Fast Moving Consumer Goods
Other Agricultural Products

Share price

₹8.00+0.34 (+4.44%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded. Earlier history is omitted pending corporate-action verification.

52W high: —
52W low: —
Off 52W high: —
1M return: -20.63%
3M return: -2.79%
6M return: -30.50%
1Y return: —
20D avg volume: 44,931
50 DMA: ₹8.85
200 DMA: —

Key ratios Consolidated

Market cap: ₹62.45 Cr
Current price: ₹8.00
52W high / low: — / —
Face value: ₹10.00
P/E: 14.32
P/B: —
EPS (TTM): ₹0.56
Book value / share: —
ROE: —
ROCE: 6.20%
Operating margin: —
Net margin: —
Debt / equity: 1.26
Net debt: ₹124.05 Cr
Interest cover: 1.03
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 217.9 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	37.71	37.76	35.02	35.95	29.10	50.57	17.32	30.81	31.53	44.38	39.09	40.44
	1.59	0.88	0.83	1.80	1.06	2.78	0.00	0.30	0.04	1.03	0.08	0.09
	39.30	38.65	35.85	37.75	30.16	53.35	17.32	31.11	31.57	45.41	39.17	40.53
	38.71	39.76	35.70	36.69	29.95	61.66	16.89	29.92	30.63	40.68	38.09	34.99
	32.46	25.27	26.10	21.94	20.76	38.96	10.05	17.09	16.67	26.10	24.45	24.52
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	2.92	4.30	3.20	3.98	2.69	6.19	3.42	5.14	5.72	8.46	4.97	5.11
	1.37	3.08	2.47	1.89	2.17	7.07	1.03	1.42	2.25	5.51	1.41	0.93
	1.10	1.13	1.01	1.30	0.86	-1.72	1.46	2.79	0.83	0.96	1.03	0.91
	1.27	5.98	2.93	7.59	3.47	9.93	0.85	5.69	3.41	5.74	—	—
	0.59	-1.11	0.14	1.06	0.21	-8.32	0.43	1.20	0.94	4.73	1.08	5.54
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	0.59	-1.11	0.14	1.06	0.21	-8.32	0.43	1.20	0.94	4.73	1.08	5.54
	0.05	-2.09	0.03	0.15	0.05	0.21	0.08	0.02	0.10	0.00	0.00	0.00
	0.54	0.98	0.12	0.91	0.16	-8.53	0.35	1.22	0.85	4.73	1.08	5.54
	0.06	0.24	0.01	0.09	0.03	-1.42	0.05	0.13	0.10	0.58	0.22	0.89
Key metrics
	3.06	3.10	3.62	4.25	3.24	-2.97	2.92	5.41	4.02	11.20	3.52	7.38
	8.10%	8.20%	10.30%	11.80%	11.10%	-5.90%	16.90%	17.60%	12.70%	25.20%	9.00%	18.20%
	1.40%	2.60%	0.30%	2.50%	0.50%	-16.90%	2.00%	4.00%	2.70%	10.70%	2.80%	13.70%
	—	1.20%	—	1.40%	—	-0.80%	—	—	—	—	—	—
	29.60%	-25.30%	102.20%	16.70%	-7.70%	13.90%	-55.70%	-23.80%	—	—	—	—
	237.50%	111.50%	-65.70%	-25.40%	-81.20%	-280.30%	-67.60%	-78.00%	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	146.44	137.83	130.23	166.23
	5.10	4.57	3.13	1.22
	151.55	142.40	133.35	167.44
	150.86	142.10	139.10	156.47
	105.77	94.07	82.77	103.22
	0.00	0.00	0.00	—
	14.40	14.16	20.47	23.93
	8.81	9.60	11.76	9.88
	4.54	4.30	3.37	3.80
	17.77	19.97	20.73	21.72
	0.68	0.30	-5.74	10.97
	0.00	0.00	0.00	0.00
	0.68	0.30	-5.74	10.97
	-1.86	1.66	0.36	0.55
	2.55	1.96	-6.11	10.42
	0.40	0.48	-1.35	1.40
Key metrics
	14.03	14.20	9.39	24.65
	9.58%	10.30%	7.20%	14.80%
	1.74%	1.40%	-4.70%	6.30%
	—	6.20%	3.60%	—
	14.59%	5.80%	-21.70%	—
	—	132.10%	-158.60%	—
	—	24.04	-8.12	—
	—	16.30	1.10	—
	—	1.26	1.37	—
	—	124.05	136.79	—
	—	217.9	214.3	—
Balance sheet
	—	253.43	268.17	—
	—	158.72	177.94	—
	—	4.26	0.29	—
	—	58.58	58.69	—
	—	37.78	41.34	—
	—	33.25	40.80	—
	—	36.91	34.34	—
	—	14.06	23.58	—
	—	92.98	102.48	—
	—	128.31	137.08	—
	—	70.42	71.66	—
	—	57.89	65.42	—
	—	102.08	99.92	—
Cash flow
	—	31.95	-6.74	—
	—	-12.73	24.74	—
	—	-15.16	-18.30	—
	—	7.91	1.38	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	4.15	4.08	5.20	5.93	6.69	9.28	8.19	9.51	10.79	15.80	13.69	16.01
	0.19	0.82	0.68	1.82	0.89	0.93	0.66	0.89	1.03	3.45	0.08	0.09
	4.34	4.90	5.88	7.75	7.58	10.22	8.85	10.40	11.82	19.25	13.77	16.10
	4.15	8.42	5.77	7.13	7.41	10.02	8.71	10.27	11.65	17.62	13.51	15.69
	1.89	2.20	2.04	3.06	3.35	2.80	3.34	3.80	4.85	7.62	7.72	10.29
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	1.01	2.58	1.38	1.56	1.50	3.30	2.69	3.20	4.04	4.90	3.27	3.91
	0.76	0.54	1.09	0.99	1.32	2.39	1.52	1.89	1.52	2.47	0.78	0.62
	0.12	2.19	0.14	0.17	0.15	0.06	0.32	0.32	0.32	0.35	0.37	0.37
	0.37	0.91	1.12	1.36	1.08	1.46	—	1.06	—	—	1.38	—
	0.19	-3.52	0.11	0.63	0.17	0.20	0.14	0.13	0.17	1.62	0.26	0.41
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	0.19	-3.52	0.11	0.63	0.17	0.20	0.14	0.13	0.17	1.62	0.26	0.41
	0.05	0.28	0.03	0.16	0.04	0.00	0.04	0.03	0.04	1.55	—	—
	0.15	-3.59	0.08	0.47	0.13	0.20	0.11	0.10	0.13	0.07	0.26	0.41
	0.03	0.05	0.01	0.10	0.03	0.00	0.02	0.02	0.03	0.08	0.06	0.12
Key metrics
	1.07	-0.79	1.34	1.79	1.64	2.65	1.98	2.34	2.01	4.44	1.41	1.40
	25.80%	-19.40%	25.80%	30.20%	24.50%	28.60%	24.20%	24.60%	18.60%	28.10%	10.30%	8.70%
	3.60%	-88.00%	1.50%	7.90%	1.90%	2.20%	1.30%	1.10%	1.20%	0.40%	1.90%	2.60%
	—	-3.60%	—	2.00%	—	3.70%	—	—	—	—	—	—
	-38.00%	-56.00%	-36.50%	-37.60%	-38.00%	-41.30%	-40.20%	-40.60%	—	—	—	—
	15.40%	-1,895.00%	-27.30%	370.00%	0.00%	185.70%	-57.70%	-75.60%	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	19.36	21.90	37.77	62.32
	3.51	4.21	3.52	3.62
	22.87	26.11	41.29	65.94
	25.47	24.91	40.64	62.93
	9.19	10.65	14.78	35.15
	0.00	0.00	0.00	—
	6.53	7.01	13.24	15.69
	3.38	3.95	7.32	4.83
	2.62	0.64	1.02	1.45
	3.76	2.65	4.27	—
	-2.59	1.21	0.65	3.01
	0.00	0.00	0.00	—
	-2.59	1.21	0.65	3.01
	0.52	0.51	-0.80	1.55
	-2.89	0.70	1.45	1.46
	0.19	0.25	0.00	0.32
Key metrics
	3.41	5.80	8.99	9.29
	17.61%	26.50%	23.80%	14.90%
	-14.93%	3.20%	3.80%	2.30%
	—	6.20%	11.50%	—
	-42.50%	-42.00%	-39.40%	—
	-635.19%	-51.70%	-0.70%	—
	—	-14.10	16.50	—
	—	-20.14	11.97	—
	—	1.06	1.11	—
	—	59.12	61.60	—
	—	274.9	92.7	—
Balance sheet
	—	121.93	130.68	—
	—	74.22	80.62	—
	—	0.03	0.06	—
	—	16.10	16.46	—
	—	1.76	1.69	—
	—	—	10.36	—
	—	12.05	12.83	—
	—	1.36	8.56	—
	—	38.84	61.48	—
	—	59.15	61.66	—
	—	32.52	48.02	—
	—	26.63	13.64	—
	—	56.03	55.33	—
Cash flow
	—	-14.10	17.35	—
	—	1.40	-1.34	—
	—	12.67	-16.22	—
	—	0.00	0.85	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -42.50%
Profit YoY (TTM): -635.19%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +14.59%
Profit YoY (TTM): +137.50%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 32.93%

Holder	Type	Holding	Previous	Change
G Swaminathan	Promoter	9.07%	—	—
Jayaseelan Singaravelu	Public	8.12%	—	—
Sayee Sundar Kasiraman	Promoter	5.78%	—	—
S Indirakumar	Promoter	4.61%	—	—
I Umasundari	Promoter	4.61%	—	—
Sonal Lohia	Public	3.92%	—	—
Ajitkumar Chimanbhai Patel	Public	2.89%	—	—
M Ramesh	Promoter	2.31%	—	—
Jothi Ramesh	Promoter	2.31%	—	—
Lrsd Securities Pvt Ltd	Public	2.03%	—	—
S Prakash	Public	1.55%	—	—
S I Dinesh Kumar	Promoter	1.54%	—	—
Thirumeni Thiruselvaraja	Promoter	1.54%	—	—
Karuppannan A	Public	1.28%	—	—
V Agathiyan	Promoter	1.16%	—	—

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
LT Foods Limited	14,255	410.50	21.71	18.40%	+24.34% TTM	+2.89% TTM	+1.71%
KRBL Ltd.	9,368	409.30	11.09	14.80%	+0.10% TTM	+38.64% TTM	+9.13%
Gujarat Ambuja Exports Ltd.	6,972	152.00	13.68	12.50%	+15.85% TTM	+147.15% TTM	+40.61%
Kaveri Seed Company Ltd	3,502	680.80	13.68	17.00%	-2.82% TTM	-15.52% TTM	-33.94%
TRUALT BIOENERGY LIMITED	3,160	368.50	14.08	10.80%	—	—	-12.96%
Amir Chand Jagdish Kumar (Exports) Limited	2,305	222.60	17.42	24.10%	—	—	—
GRM Overseas Ltd.	1,929	93.08	25.19	20.20%	+43.22% TTM	+22.87% TTM	-34.35%
SANSTAR LIMITED S	1,925	96.14	43.70	5.40%	+2.23% TTM	+63.20% TTM	+1.29%
AVT Natural Products Ltd.	1,485	97.52	17.72	16.20%	+40.77% TTM	+54.05% TTM	+33.97%
CHAMAN LAL SETIA EXPORTS LIMITED S	1,403	282.15	11.21	17.80%	+2.68% TTM	+22.80% TTM	+3.75%
Gulshan Polyols Ltd.	990	158.80	—	7.60%	+35.17% TTM	+92.81% TTM	+1.21%
REGAAL RESOURCES LIMITED S	888	86.18	14.83	11.50%	—	—	-3.19%
BOMBAY SUPER HYBRID SEEDS LIMITED S	882	84.05	—	26.10%	—	—	—
TRUE GREEN BIO ENERGY LIMITED S	623	189.15	8.81	14.00%	+5,109.34% TTM	+3,389.77% TTM	+159.18%
MANGALAM GLOBAL ENTERPRISE LIMITED	593	17.98	15.32	32.40%	+44.23% TTM	+8.17% TTM	+24.09%
Modi Naturals Limited	452	340.05	8.65	23.50%	+7.35% TTM	+53.54% TTM	-23.45%
Sarveshwar Foods Limited	447	3.63	13.54	14.40%	+16.42% TTM	+7.00% TTM	-28.40%
Sukhjit Starch & Chemicals Ltd.	444	142.05	12.99	8.80%	—	—	-12.31%
SC Agrotech Limited S	337	44.37	14.74	4.00%	+1,787.46% TTM	+5,345.24% TTM	+161.00%
Jattashankar Industries Limited S	313	71.40	17.08	6.40%	+4,061.21% TTM	+473.47% TTM	+139.36%
Sayaji Industries Limited	280	110.95	11.36	12.00%	+6.27% TTM	+214.51% TTM	+37.83%
Nath Biogene India Ltd.	257	135.10	7.01	8.90%	+21.02% TTM	-13.92% TTM	-21.91%
AELEA COMMODITIES LIMITED	224	109.75	—	28.10%	—	—	-40.68%
PRIME FRESH LIMITED	220	158.15	14.23	19.80%	—	—	-45.31%
Tierra Agrotech Limited	189	28.76	-27.00	-6.90%	+66.35% TTM	+37.42% TTM	-52.94%
Indrayani Biotech Ltd.	62	8.00	14.32	6.20%	+14.59% TTM	+137.50% TTM	—

Filings & corporate actions

Recent announcements

Revised outcome of the Rights Issue Committee held on November 03, 20263 Nov 2026 · Corp. Action / Bonds / Right issue
Outcome of the Rights Issue Committee Meeting held on November 03, 20263 Nov 2026 · Corp. Action / Bonds / Right issue
Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve 1. Notice of the 34th Annual ....3 Nov 2026 · Board Meeting / Board Meeting
Appointment of Ms. Nattery Srinivasan Poornima, Company Secretary in Practice, as the Secretarial Auditor of the Company.2 Nov 2026 · Company Update / General
Resignation of Mr. C. S. Shanmuga Sundar as a Company Secretary and Compliance Officer of the Company.2 Nov 2026 · Company Update / Resignation of Company Secretary / Compliance Officer
Outcome of the Board Meeting held on November 02, 2026.2 Nov 2026 · Others / Outcome without intimation
Update on Income Tax Recovery Proceeding.21 Oct 2026 · Company Update / General
Resignation of Mr. K.S. Vaidyanathan, Independent Director from Board of Directors of Indrayani Biotech Limited.13 Oct 2026 · Company Update / Change in Management
Compliance Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulation 2018, for the quarter ended 30th September 2026.7 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Unaudited Standalone & Consolidated Financial Results for quarter ended June 30, 2026 along with Limited Review Report.7 Oct 2026 · Result / Financial Results
Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30th June 2026 Along With Limited Review Report.7 Oct 2026 · Board Meeting / Outcome of Board Meeting
Indrayani Biotech Limited has informed the Sale of Shares of Subsidiary Company under Regulation 30 of SEBI LODR 201530 Sep 2026 · Company Update / General
Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results ....30 Sep 2026 · Board Meeting / Board Meeting
Intimation of Closure of Trading Window for the Quarter and Half year Ending 30th September, 202629 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
News Paper Publication as per Regulation 84 of SEBI(Issue of Capital and Disclosure Requirements), 2018 with respect to Rights Issue.15 Sep 2026 · Company Update / Newspaper Publication
Letter of Offer for Rights Issue9 Sep 2026 · Company Update / General
Outcome of the Rights Issue Committee held 09th September,2026.9 Sep 2026 · Corp. Action / Bonds / Right issue
Appointment of Mr. C.S. Shanmuga Sundar, as a company secretary and compliance officer of the company. W.e.f. 09th September, 2026.9 Sep 2026 · Company Update / Appointment of Company Secretary / Compliance Officer
Resignation of Mr. K. Ravichandran as the Secretarial Auditor of the Company.7 Sep 2026 · Company Update / General
Approval received for AGM Extension (FY 2025-26)7 Sep 2026 · Company Update / General
News paper Publication of audited financials results (Standalone & Consolidated) for quarter and year ended March 31, 2026.20 Aug 2026 · Company Update / Newspaper Publication
Audited financial results for quarter and year ended March 31, 2026 along with report of statutory auditors.19 Aug 2026 · Company Update / General
Audited Standalone & consolidated financial results for the quarter and year ended 31st March 2026 along with report of statutory auditors.17 Aug 2026 · Board Meeting / Outcome of Board Meeting
Audited Standalone & Consolidated financial results for the quarter and year ended March 31, 2026 along with auditors report.17 Aug 2026 · Result / Financial Results
Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve Indrayani Biotech Ltd has ....12 Aug 2026 · Board Meeting / Board Meeting
Company has received GST revocation order16 Jul 2026 · Company Update / General
Company has received IT Order15 Jul 2026 · Company Update / General
Company has received IT order15 Jul 2026 · Company Update / General
Compliance Certificate Under Reg 74(5) of SEBI (Depositories and Participants) Regulation, 2018, for the quarter ended on 30th June, 2026.6 Jul 2026 · Company Update / General
Intimation of Closure of Trading Window for the Quarter Ending 30th June, 2026.27 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Outcome of the Rights issue Committee Meeting Held on 22nd June, 202622 Jun 2026 · Company Update / General
Resignation of Mrs. Ramya Ravi as the Company Secretary and Compliance Officer of the Company3 Jun 2026 · Company Update / Resignation of Company Secretary / Compliance Officer
Annual Secretarial Compliance Report for the year ended 31st March, 202627 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Delay in financial results for the year ended 31st March, 202627 May 2026 · Result / Financial Results
Resignation letter of Mr. Indirakumar27 May 2026 · Company Update / General
Outcome of the Rights Issue Committee Meeting held on 25th May, 202625 May 2026 · Company Update / General
Outcome of the Rights issue Committee Meeting held on 28-04-2026.28 Apr 2026 · Company Update / General
Company has received an IT Demand Notice25 Apr 2026 · Company Update / General
Intimation of ISIN for Rights Entitlement to be credited for the purpose of Rights Issue of Indrayani Biotech Limited21 Apr 2026 · Company Update / General
Outcome of the Rights Issue Committee Meeting9 Apr 2026 · Corp. Action / Bonds / Right issue

Corporate actions

Purpose	Ex date	Record date	Payment date
Right Issue of Equity Shares	28 Apr 2026	28 Apr 2026	—

Board meetings

7 Oct 2026 Board Meeting - Financial Results
17 Aug 2026 Board Meeting - Financial Results